These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 36748811)
1. 4-Nerolidylcatechol (4-NC) and Docetaxel Synergize in Controlling Androgen- independent Prostate Cancer Cells. da Silva Guimarães G; Cordeiro AO; Gazolla MC; Vecchi L; Pereira Zoia MA; de Vasconcelos Azevedo FVP; Moreira Campos I; de Souza Costa D; Soares Mota ST; Alves Ribeiro M; Goulart LR; da Silva Filho AA; Araújo TG Curr Top Med Chem; 2023; 23(11):943-955. PubMed ID: 36748811 [TBL] [Abstract][Full Text] [Related]
2. Rapamycin enhances the susceptibility of both androgen-dependent and -independent prostate carcinoma cells to docetaxel. Liu QJ; Xu XH; Shang DH; Tian Y; Lü WC; Zhang YH Chin Med J (Engl); 2010 Feb; 123(3):356-60. PubMed ID: 20193259 [TBL] [Abstract][Full Text] [Related]
3. Docetaxel down-regulates the expression of androgen receptor and prostate-specific antigen but not prostate-specific membrane antigen in prostate cancer cell lines: implications for PSA surrogacy. Kuroda K; Liu H; Kim S; Guo M; Navarro V; Bander NH Prostate; 2009 Oct; 69(14):1579-85. PubMed ID: 19575420 [TBL] [Abstract][Full Text] [Related]
4. Sensitization to docetaxel in prostate cancer cells by green tea and quercetin. Wang P; Henning SM; Heber D; Vadgama JV J Nutr Biochem; 2015 Apr; 26(4):408-15. PubMed ID: 25655047 [TBL] [Abstract][Full Text] [Related]
5. Green tea and quercetin sensitize PC-3 xenograft prostate tumors to docetaxel chemotherapy. Wang P; Henning SM; Magyar CE; Elshimali Y; Heber D; Vadgama JV J Exp Clin Cancer Res; 2016 May; 35():73. PubMed ID: 27151407 [TBL] [Abstract][Full Text] [Related]
7. The Combination of Omega-3 Stearidonic Acid and Docetaxel Enhances Cell Death over Docetaxel Alone in Human Prostate Cancer Cells. Mansour M; van Ginkel S; Dennis JC; Mason B; Elhussin I; Abbott K; Pondugula SR; Samuel T; Morrison E J Cancer; 2018; 9(23):4536-4546. PubMed ID: 30519360 [No Abstract] [Full Text] [Related]
8. A new flavonoid derivative exerts antitumor effects against androgen-sensitive to cabazitaxel-resistant prostate cancer cells. Naito R; Kano H; Shimada T; Makino T; Kadomoto S; Iwamoto H; Yaegashi H; Izumi K; Kadono Y; Nakata H; Saito Y; Goto M; Nakagawa-Goto K; Mizokami A Prostate; 2021 Apr; 81(5):295-306. PubMed ID: 33493355 [TBL] [Abstract][Full Text] [Related]
9. Androgens modify therapeutic response to cabazitaxel in models of advanced prostate cancer. Begemann D; Wang Y; Yang W; Kyprianou N Prostate; 2020 Sep; 80(12):926-937. PubMed ID: 32542812 [TBL] [Abstract][Full Text] [Related]
10. Combination treatment of docetaxel with caffeic acid phenethyl ester suppresses the survival and the proliferation of docetaxel-resistant prostate cancer cells via induction of apoptosis and metabolism interference. Fu YK; Wang BJ; Tseng JC; Huang SH; Lin CY; Kuo YY; Hour TC; Chuu CP J Biomed Sci; 2022 Feb; 29(1):16. PubMed ID: 35197069 [TBL] [Abstract][Full Text] [Related]
11. Marked improvement of cytotoxic effects induced by docetaxel on highly metastatic and androgen-independent prostate cancer cells by downregulating macrophage inhibitory cytokine-1. Mimeault M; Johansson SL; Batra SK Br J Cancer; 2013 Mar; 108(5):1079-91. PubMed ID: 23449353 [TBL] [Abstract][Full Text] [Related]